Jefferies Resumes Sequenom (SQNM) at Buy
Jefferies resumes coverage on Sequenom (NASDAQ: SQNM) with a Buy rating and a price target of $5.00 (from $4.50).
Analyst Brandon Couillard said, "Our revised revenue and EPS forecasts reflect the effects of SQNM’s recent divestiture of its Biosciences unit, as well as expectations for a profitability & cash flow inflection in 4Q14."
The firm lifted FY 2014 EPS from ($0.75) to ($0.31).
Shares of Sequenom closed at $3.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q
- Jefferies Raises Price Target on Texas Instruments (TXN) Following 3Q Report
- Jefferies Remains Sidelined on Shutterfly (SFLY) - PT to $52
Create E-mail Alert Related CategoriesAnalyst Comments, Hot New Coverage, New Coverage
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!